Stockreport

Nuvation Bio Q4 Earnings Call Highlights [Yahoo! Finance]

Nuvation Bio Inc. Class A  (NUVB) 
PDF in 2025 (216 in Q4) and prescriptions ramping roughly six times faster than prior ROS1 TKI launches, though early use skewed to later-line patients has limited near-term [Read more]